Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Hydroxychloroquine. Photo: George Frey/AFP via Getty Images
Editor’s note: The study referenced in this story has been retracted by the medical journal The Lancet due to questions on the veracity of its primary data sources. Read more here.
Coronavirus patients who took hydroxychloroquine or its related drug chloroquine were more likely to die or develop an irregular heart rhythm that can lead to sudden cardiac death, compared to those who did nothing, a retrospective review published in The Lancet shows.
Why it matters: Despite warnings from the Food and Drug Administration, President Trump has insisted the anti-malarial drug as a "game-changer" and admitted he has taken it as a preventative even though the drug is unproven.
The big picture: The medical journal's review consisted of 96,000 hospitalized patients diagnosed with the coronavirus in six continents, the largest analysis of medical records on the drug, between Dec. 20, 2019, and April 14, 2020.
- About 15,000 of the 96,000 patients were treated with hydroxychloroquine or chloroquine alone, or combined with an antibiotic known as a macrolide.
The findings: Those given the drug alone had a 34% increased risk of dying and a 137% increased risk of heart arrhythmias.
- Those who took the drug paired with an antibiotic had a 45% increased risk of death and a 411% risk of heart arrhythmias. This combination is one President Trump has been encouraging.
The mean age of patients was 54 years old and 53% were men.
- Those excluded were those on mechanical ventilators or who received remdesivir, an antiviral drug made by Gilead Sciences.
The bottom line: The FDA has adamantly warned against taking hydroxychloroquine or chloroquine because of the risk of heart complications and unproven claims it prevents COVID-19 infections.
Go deeper: Stunned Fox News host reacts to Trump taking hydroxychloroquine